Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02920008
Title Phase 3 Randomized, Open-Label Study of Guadecitabine vs Treatment Choice in Previously Treated Acute Myeloid Leukemia
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Astex Pharmaceuticals
Indications

acute myeloid leukemia

Therapies

Decitabine

Azacitidine

Cytarabine

Guadecitabine

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | BEL


No variant requirements are available.